Bainville-sur-Madon, France

Céline Huselstein

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Centre Hospitalier Regional Universitaire De Nancy, Universite Dé Lorraine. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Céline Huselstein. Retrieved from https://idiyas.com/inventor/céline-huselstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Céline Huselstein: Innovator in Stem Cell Research

Introduction

Céline Huselstein is a notable inventor based in Bainville-sur-Madon, France. He has made significant contributions to the field of stem cell research, particularly in the therapeutic applications of mesenchymal stem cells.

Latest Patents

Céline Huselstein holds 1 patent for his invention titled "Mesenchymal stem cells obtained from Wharton's jelly for the treatment of sepsis." This patent discloses a method for preparing human mesenchymal stem cells derived from Wharton's jelly, along with their therapeutic uses, especially in treating sepsis and septic shock. The treatment involves administering a pharmaceutical composition that includes these stem cells and a pharmaceutically acceptable excipient.

Career Highlights

Throughout his career, Céline has worked with esteemed institutions such as Université de Lorraine and Centre Hospitalier Régional Universitaire de Nancy. His work has focused on advancing the understanding and application of stem cell therapies in clinical settings.

Collaborations

Céline has collaborated with notable colleagues, including Danièle Bensoussan and Sébastien Gibot, contributing to the advancement of research in his field.

Conclusion

Céline Huselstein's innovative work in stem cell research highlights the potential of mesenchymal stem cells in treating critical conditions like sepsis. His contributions continue to pave the way for future advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…